1. Academic Validation
  2. Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53

Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53

  • Cancer Res. 2020 Jun 1;80(11):2175-2189. doi: 10.1158/0008-5472.CAN-19-1912.
Yunzhao Chen  # 1 2 Huahua Xin  # 1 Hao Peng  # 1 Qi Shi 1 Menglu Li 1 Jie Yu 2 Yanxia Tian 1 Xueping Han 1 Xi Chen 1 Yi Zheng 3 Jun Li 4 Zhihao Yang 1 Lan Yang 1 Jianming Hu 1 Xuan Huang 5 Zheng Liu 5 Xiaoxi Huang 5 Hong Zhou 6 Xiaobin Cui 7 Feng Li 7 5
Affiliations

Affiliations

  • 1 Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China.
  • 2 The People's Hospital of Suzhou National Hi-Tech District, Suzhou, China.
  • 3 Department of Gastroenterology, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China.
  • 4 Department of Ultrasound, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China.
  • 5 Department of Pathology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • 6 Bone Research Program, ANZAC Research Institute, The University of Sydney, Sydney, Australia.
  • 7 Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China. [email protected] [email protected].
  • # Contributed equally.
Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the deadliest malignant diseases. Multiple studies with large clinic-based cohorts have revealed that variations of Phospholipase C epsilon 1 (PLCE1) correlate with esophageal Cancer susceptibility. However, the causative role of PLCE1 in ESCC has remained elusive. Here, we observed that hypomethylation-mediated upregulation of PLCE1 expression was implicated in esophageal carcinogenesis and poor prognosis in ESCC cohorts. PLCE1 inhibited cell Autophagy and suppressed the protein expression of p53 and various p53-targeted genes in ESCC. Moreover, PLCE1 decreased the half-life of p53 and promoted p53 ubiquitination, whereas it increased the half-life of mouse double minute 2 homolog (MDM2) and inhibited its ubiquitination, leading to MDM2 stabilization. Mechanistically, the function of PLCE1 correlated with its direct binding to both p53 and MDM2, which promoted MDM2-dependent ubiquitination of p53 and subsequent degradation in vitro. Consequently, knockdown of PLCE1 combined with transfection of a recombinant adenoviral vector encoding wild-type p53 resulted in significantly increased levels of Autophagy and Apoptosis of esophageal Cancer in vivo. Clinically, the upregulation of PLCE1 and mutant p53 protein predicted poor overall survival of patients with ESCC, and PLCE1 was positively correlated with p53 in ESCC cohorts. Collectively, this work identified an essential role for PLCE1- and MDM2-mediated ubiquitination and degradation of p53 in inhibiting ESCC Autophagy and indicates that targeting the PLCE1-MDM2-p53 axis may provide a novel therapeutic approach for ESCC. SIGNIFICANCE: These findings identify hypomethylation-mediated activation of PLCE1 as a potential oncogene that blocks cellular Autophagy of esophageal carcinoma by facilitating the MDM2-dependent ubiquitination of p53 and subsequent degradation. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/80/11/2175/F1.large.jpg.

Figures
Products